09 March 2026
Announcement
...
-
29 May 2026
-
29 May 2026
Ipsen announces the launch of an Employee Shareholding Plan
Ipsen announces the launch of an employee shareholding plan...
-
01 April 2026
-
01 April 2026
Ipsen announces the availability of its 2025 Universal Registration Document
Ipsen announces the availability of its 2025 Universal Registration Document...
-
23 July 2025
-
23 July 2025
Ipsen announces changes to its Executive Committee
PARIS, FRANCE, 23 July 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care biopharmaceutical company, today announced the following changes to its Executive Committee:...
-
30 July 2026
- 1 min read
-
30 July 2026
- 1 min read
Excellent growth and progress in H1 2026
What a start to 2026! We announced excellent financial results today. ...
-
03 April 2026
-
03 April 2026
Ipsen announces that Beech Tree has obtained an exemption from the obligation to submit a public tender offer
PARIS, FRANCE, 3 April 2026 — Ipsen (Euronext: IPN; ADR: IPSEY) announces that Beech Tree — which directly and indirectly holds 26.03% of Ipsen S.A.’s share capital and 33.05% of its voting rights — has obtained from the French Financial Markets A...
-
19 March 2025
-
19 March 2025
Ipsen announces issuance of €500 million inaugural Rated Public Bond
Transaction follows Investment Grade ratings assignment from both S&P and Moody’s...
-
22 October 2025
- 1 min read
-
22 October 2025
- 1 min read
-
14 October 2025
-
14 October 2025
Ipsen announces the conclusion of an agreement between its main shareholders representing 52.06% of the capital and 66.15% of the voting rights
PARIS, FRANCE, 14 OCTOBER 2025 - Ipsen (Euronext: IPN: ADR: IPSEY) announced today that its Board of Directors has been informed of the conclusion of a new agreement1 between Highrock (controlled by Anne Beaufour), Beech Tree (controlled by Henri Beaufour)...
-
22 October 2025
-
22 October 2025
Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance
PARIS, FRANCE, 22 October 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the year to date and the third quarter of 2025....